Scientists make new Covid variant with 80% kill rate in mice

10/18/2022

Boston University has created a new Covid-19 variant which resulted in an 80% kill rate in mice, according to a new research paper.

The research hopes to better understand the role played by the virus' spike protein in terms of how harmful a variant is.

To do this, scientists at Boston University's biosafety 4 research lab attached the more immune evading Omicron spike protein to the "backbone" of an original Covid virus from the start of the pandemic.

"We generated chimeric recombinant SARS-CoV-2 encoding the S gene of Omicron in the backbone of an ancestral SARS-CoV-2 isolate and compared this virus with the naturally circulating Omicron variant," the paper published on biorxiv awaiting peer review reads.

Unusual Whales does not confirm the information's truthfulness or accuracy of the associated references, data, and cannot verify any of the information. Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Options, investing, trading is risky, and losses are more expected than profits. Please do own research before investing. Please only subscribe after reading our full terms and understanding options and the market, and the inherent risks of trading. It is highly recommended not to trade on this, or any, information from Unusual Whales. Markets are risky, and you will likely lose some or all of your capital. Please check our terms for full details.

Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. See terms for more information.

The Blubber

FEATURED NEWS

Chinese companies that sell products on Amazon, AMZN, are preparing to hike prices for the U.S....

The US House has voted on the SAVE Act, and passed it, requiring citizens to have proof of citi...

RFK JR has just said at Trump's Cabinet meeting: We will know by September what caused the Auti...

President Donald Trump is reportedly looking into possibly delisting Chinese public companies f...

Stay Updated